Albert-Marí, AsunciónJiménez-Pulido, InmaculadaSan José-Ruiz, BegoñaConde Estévez, DavidGil-Lemus, Mª ÁngelesCercós-Lletí, Ana CristinaEsteban-Mensua, M. JesúsDíaz-Carrasco, Mª Sacramento2022-11-212022-11-212022Albert-Marí A, Jiménez-Pulido I, José-Ruiz BS, Conde-Estévez D, Gil-Lemus MÁ, Cercós-Lletí AC, et al. Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO). J Oncol Pharm Pract. 2022 Apr 26: 10781552221091914. DOI: 10.1177/107815522210919141078-1552http://hdl.handle.net/10230/54921Data de publicació electrónica: 26-04-2022application/pdfengAlbert-Marí A, Jiménez-Pulido I, José-Ruiz BS, Conde-Estévez D, Gil-Lemus MÁ, Cercós-Lletí AC, et al. Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO), J Oncol Pharm Pract. 2022 Apr 26: 10781552221091914. Copyright © 2022. DOI: 10.1177/10781552221091914.Medicaments antineoplàsticsOncologiainfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1177/10781552221091914info:eu-repo/semantics/openAccess